Here you will find news and events about Pharmacogenetics.

News Archive

2017 October 7 

We are happy to announce that EU-Pic will collaborate with ESPT in the division of clinical implementation.
More info.



2016 Monday April 18 

We are deeply saddened by the news that our EU-PIC Board member Prof Dr Gerard Siest passed away on April 9th. 
He will be missed enormously. More info can be found at

2016 Monday 30 March

  • Combined proposal ready
  • Including comments on budget.
  • Discussion and decision
  • Planned for April 2 in Istanbul
  • From 13:00-18:00

2016 Monday 23 March

  • Input all members on WP drafts received. 
  • Istanbul meeting gets more shape. 
  • First proposal was sent out.

2016 Monday 09 March

  • First drafts of the WPs received. 
  • WP TCs are planned this week.
  • Barbara Zehnbauer, ISsam Zineh and John van den Anker joined the Advisory Board.

2016 Monday 02 March

Formation External Advisory Board, with Michael Eichelbaum, Mary Relling, Dick Weinshilbaum, Sander Vinks, Maarten Akkerman, Barbara Prainsack and Cecile Janssens.

2016 Thursday 20 February

  • Workpackage templates have been sent out. 
  • WP leaders will make a first draft for Feb 26.

2016 Thursday 12 February

The Eu-PIC meeting on Febr. 10-11 in Rotterdam was a great success, with in total 65 participants.

2016 Wednesday 04 February

  • Hotel venue for Feb 10-11
  • Mainport Design Hotel Rotterdam
  • 10 min from Central Train Station and 10 min from Erasmus MC

2016 Tuesday 03 February

A total of 60 participants registered for the meeting in Rotterdam.

2016 Thursday 30 January

Organisation for the first Eu-PIC consortiummeeting in full progress

2016 Wednesday 29 January

Agreement with KNMP for Stage 2

2016 Tuesday 28 January

Workpackage leaders appointed 

2016 Monday 27 February

EU-PIC was selected for submitting a Stage 2 proposal.


Countries Participating

  • Netherlands
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Poland
  • Portugal
  • Slovenia
  • Spain
  • Sweden
  • Switserland
  • Turkey
  • UK

Contact | Login | Registration


Our purpose: implementing and supporting Pharmacogenetics for the most important and actionable pharmacogenetic markers into clinical care and monitor uptake and experiences.

Personalised medicine

Personalised medicine has the potential to respond to, amongst others, the increasing burden of chronic disease and the complexity of co-morbidities and in doing so contribute to the sustainability of health and care systems. 

Where to find us

's Gravendijkwal 230
3015 CE Rotterdam
Prof. Dr. R.H.N. van Schaik | Dept. Clinical Chemistry, Erasmus MC Rotterdam